ArticleFrontiers in oncology2021

Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study.

Kenji Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.